Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.25 - $4.05 $26,280 - $47,304
-11,680 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$4.08 - $7.83 $4,080 - $7,830
-1,000 Reduced 7.89%
11,680 $48,000
Q2 2021

Aug 12, 2021

BUY
$6.78 - $9.04 $6,780 - $9,040
1,000 Added 8.56%
12,680 $100,000
Q1 2021

May 24, 2021

BUY
$8.18 - $23.98 $95,542 - $280,086
11,680 New
11,680 $99,000

Others Institutions Holding IMRA

About IMARA Inc.


  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.